AVIR Stock Ownership Activity
ATEA PHARMACEUTICALS INC 13F holders
No value investing guru has made any change to the ATEA PHARMACEUTICALS INC (AVIR) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying AVIR now?
According to the latest SEC filing(s) ATEA PHARMACEUTICALS INC (AVIR) has not been purchased by any super investor.
To see more about who is investing in ATEA PHARMACEUTICALS INC (AVIR), please go to the AVIR ownership page.
2021 Q4
(1 result)
Current price: $3.37
90.39%
Reported price*: $35.06
2021 Q3
(1 result)
Current price: $3.37
90.39%
Reported price*: $35.06
2 of 2
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.